SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-24724"
 

Search: onr:"swepub:oai:DiVA.org:uu-24724" > Angiotensin II type...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Chu, Kwan Yi (author)

Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes

  • Article/chapterEnglish2006

Publisher, publication year, extent ...

  • American Diabetes Association,2006
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-24724
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-24724URI
  • https://doi.org/10.2337/diabetes.55.02.06.db05-1022DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • We identified an angiotensin-generating system in pancreatic islets and found that exogenously administered angiotensin II, after binding to its receptors (angiotensin II type 1 receptor [AT1R]), inhibits insulin release in a manner associated with decreased islet blood flow and (pro)insulin biosynthesis. The present study tested the hypothesis that there is a change in AT1R expression in the pancreatic islets of the obesity-induced type 2 diabetes model, the db/db mouse, which enables endogenous levels of angiotensin II to impair islet function. Islets from 10-week-old db/db and control mice were isolated and investigated. In addition, the AT1R antagonist losartan was administered orally to 4-week-old db/db mice for an 8-week period. We found that AT1R mRNA was upregulated markedly in db/db islets and double immunolabeling confirmed that the AT1R was localized to beta-cells. Losartan selectively improved glucose-induced insulin release and (pro)insulin biosynthesis in db/db islets. Oral losartan treatment delayed the onset of diabetes, and reduced hyperglycemia and glucose intolerance in db/db mice, but did not affect the insulin sensitivity of peripheral tissues. The present findings indicate that AT1R antagonism improves beta-cell function and glucose tolerance in young type 2 diabetic mice. Whether islet AT1R activation plays a role in the pathogenesis of human type 2 diabetes remains to be determined.

Subject headings and genre

  • Angiotensin II Type 1 Receptor Blockers/*pharmacology/*therapeutic use
  • Animals
  • Blood Glucose/drug effects
  • Diabetes Mellitus; Type 2/*drug therapy/genetics
  • Disease Models; Animal
  • Gene Expression Regulation
  • Glucose Intolerance/*drug therapy
  • Insulin/metabolism
  • Insulin-Secreting Cells/cytology/*drug effects/metabolism/physiology
  • Losartan/*pharmacology/therapeutic use
  • Mice
  • Mice; Obese
  • Proinsulin/biosynthesis
  • Receptor; Angiotensin; Type 1/genetics/*metabolism

Added entries (persons, corporate bodies, meetings, titles ...)

  • Lau, Tung (author)
  • Carlsson, Per-OlaUppsala universitet,Institutionen för medicinsk cellbiologi,Endokrin diabetes och metabolism(Swepub:uu)perocarl (author)
  • Leung, Po Sing (author)
  • Uppsala universitetInstitutionen för medicinsk cellbiologi (creator_code:org_t)

Related titles

  • In:Diabetes: American Diabetes Association55:2, s. 367-3740012-17971939-327X

Internet link

Find in a library

  • Diabetes (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Chu, Kwan Yi
Lau, Tung
Carlsson, Per-Ol ...
Leung, Po Sing
Articles in the publication
Diabetes
By the university
Uppsala University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view